---
type: "NewsArticle"
title: "Blood p-tau217 levels tracked later cognitive impairment risk in older adults"
description: "A pooled observational analysis of 2,684 initially unimpaired adults linked higher blood p-tau217 with greater later risk of cognitive impairment; 10-year estimates for the highest group were less certain."
resource: "https://nootropikler.com/news/blood-ptau217-predicts-risk-of-cognitive-impairment"
tags: ["research", "brain", "cognition"]
timestamp: 2026-10-05T01:04:22Z
language: "en"
---

# Blood p-tau217 levels tracked later cognitive impairment risk in older adults

A pooled observational analysis of 2,684 initially unimpaired adults linked higher blood p-tau217 with greater later risk of cognitive impairment; 10-year estimates for the highest group were less certain.

Author: Nootropik News Editorial Team
Published: 2026-10-05T01:04:22Z
Update: 2026-10-05T01:04:22Z
News/source date: 2026-07-14
Production: AI-assisted sourced summary and translation; no independent medical expert review is claimed.

## Study design

The JAMA analysis pooled six selected observational and clinical-trial cohorts, following 2,684 adults who were cognitively unimpaired when their blood was sampled. Researchers related baseline plasma p-tau217 to later cognitive impairment and change on a cognitive composite; median follow-up was 5.4 years.

## What it found

Each standard-deviation increase in p-tau217 was associated with a higher rate of progression. Modelled absolute risk in the very-high group was 38% over five years and 78% over ten years, compared with 12% and 40% in the low group. The study estimates association and risk within these cohorts.

## Limits and interpretation

Ten-year estimates had wider uncertainty because fewer participants remained under observation that long. The cohorts were selected research samples, so estimates may not transfer directly to the general population or an individual. The paper supports further validation of prognostic models; it does not establish that biomarker testing or treatment changes outcomes in symptom-free people.

## Sources

- [Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment](https://jamanetwork.com/journals/jama/fullarticle/2851720) — 2026-07-14
